Where is your R&D budget leaking value — and where is funding slipping away?
See the current state of your R&D — portfolio health, funding and compliance readiness, technology roadmap, and collaboration — in a single picture within two weeks. Not a solution, a clear diagnosis. Delivered fully online.
Drawn from work governed as an operator inside an international agricultural-equipment OEM — where outcomes were owned, not advised. Founders & full bios →
A Clear BoundaryThis is a diagnosis, not a solution
The Diagnostic is an objective assessment process only. It shows you the real risk and opportunity map of your R&D operation — not what you want to hear.
It maps out where your problems and opportunities are; how to resolve them is a separate, later step. You are not obliged to continue with Luminairo to act on the findings; most identified actions can be carried out with your own team. The goal is to clarify the picture independently first.
What this service shows
- The health and concentration risk of your R&D portfolio
- Which projects are fundable and which programs match
- The state of your technology roadmap and capability gaps
- Whether existing R&D collaborations are working — and which new ones would close capability gaps
What this service does not
- Grant / funding application writing
- Detailed action or implementation planning
- Project-level feasibility or financial analysis
- Ongoing advisory
Why It's NeededThe visible picture can be clean. The problem is what's invisible.
An R&D organization manages what it can see. The most expensive problems, though, do not show up in the budget — because what is invisible has no trigger. No alarm goes off; the budget line simply reads "in progress." And quietly, it can cost more than all the visible problems combined.
Resource-draining projects
Projects that consume person-months out of inertia, with no strategic return left.
Missed funding
Calls that fit your projects perfectly, opening and closing without ever hitting your radar.
Roadmap blind spots
Capability gaps — AI, autonomy, electrification, digitalization — hidden behind an aging roadmap.
What You ReceiveA single R&D Current-State Assessment Report
A board-ready, scored and prioritized report — and a session where we review it together.
4-Axis Maturity Scorecard (1–5) + Profile
The current state is scored on a 1–5 scale across four axes, with findings and recommended actions for each: R&D Portfolio Health (balance, concentration risk, value vs. resource drain), Funding & Compliance Readiness (fundable projects, matching national/international programs, and the strength and defensibility of R&D documentation ahead of grant audits), Technology Roadmap (current state, target technologies, and capability gaps), and Collaboration & Partnerships (which university, consortium, and external R&D links are active and value-generating, and which are dormant and should be reactivated or closed).
Top 3 Critical Findings
The three highest-priority risks or opportunities, each flagged with its severity (high / medium) and recommended action — not a scattered list, but what to look at first.
Executive Summary & Recommended Next Steps
An executive summary of the findings; recommended next work and — if useful — its estimated scope, timeline, and budget band. Possible collaboration opportunities are noted here too.
Out of ScopeWe set expectations up front
The Diagnostic does not produce:
- A detailed action or corrective-work plan
- Grant / funding application files
- Project-level detailed feasibility or financial analysis
- Portfolio restructuring execution
- Collaboration / consortium setup
- Ongoing advisory
These are the subject of later work, if needed. This engagement does one thing: clarify the picture.
What We Need From YouInputs we review
All data you share is reviewed under a signed Non-Disclosure Agreement (NDA).
- Technology & product roadmapYour 24–36 month development plans
- R&D portfolio summariesTechnical summaries of active / planned projects
- Resource & workforce allocationStaff / project distribution, person-month breakdown
- Funding history & targetsPast applications and the programs you're targeting
ProcessFrom call to report in four steps
Intro call & NDA
We scope it together and sign the NDA.
Data handover
You share roadmap, portfolio and funding inputs.
Review & analysis
Current state mapped across the four axes.
Report + 90-min session
Report delivered and the online review session is held.
TermsFixed scope, transparent pricing
Fixed scope. The scope is set; the fee is determined by the three drivers below.
- Active project count — up to 20 active projects is standard scope; above that, delivery time and fee may increase.
- R&D team scale — standard scope covers up to 50 R&D staff; larger organizations may increase delivery time and fee.
- Delivery mode — fully online by default; on-site visits are arranged at additional cost (travel & accommodation).
Credit: if you move to a comprehensive Luminairo engagement within 30 days, 50% of this fee is credited toward it.
Payment: 100% in advance upon agreement, to reserve the slot.
Delivery: two weeks after complete inputs; fully online (on-site optional, at additional cost).
Who It's ForIs this service a fit?
A fit
Industrial and AgTech R&D organizations with a structured portfolio, an engineering team, and active R&D / funding activity — ready to face an objective picture of where they stand.
Not a fit
Early-stage, idea-only startups with no portfolio yet; firms that only want a grant application written; managements not ready to see the objective current state.
About the Diagnostic
It is a fixed-scope diagnostic. It maps the current state of your R&D across four dimensions — portfolio health, funding and compliance readiness, technology roadmap, and collaboration — in a single picture within two weeks. It is not a solution, implementation plan, or application file; it is an independent diagnosis that shows where the problems and opportunities are.
The report is delivered two weeks after complete inputs, followed by a closing session. The fee starts at €1,400 + VAT; it is fixed scope, and the price is determined by active project count, R&D team scale, and delivery mode. Standard scope covers up to 20 active projects and 50 R&D staff. The service is delivered fully online; on-site visits are arranged at additional cost.
A single R&D Current-State Assessment Report: a 1–5 maturity scorecard across four axes (R&D Portfolio Health, Funding & Compliance Readiness, Technology Roadmap, Collaboration & Partnerships) with findings and recommended actions per axis, the top three critical findings, and an executive summary with recommended next steps. It is delivered as a written report plus a 90-minute online executive review session.
Fully online by default — document review, analysis, and the executive review session are all conducted remotely. On-site visits can be arranged when needed, at additional cost (travel and accommodation).
No. The goal is to clarify the picture independently first; most identified actions can be carried out with your own team. If you choose to move to a comprehensive Luminairo engagement within 30 days, 50% of the diagnostic fee is credited toward it.
All shared data is reviewed under a signed Non-Disclosure Agreement (NDA). The main inputs reviewed are your technology and product roadmap, R&D portfolio summaries, resource/workforce allocation, and funding history and targets.
Ready to see the real picture of your R&D portfolio?
Request a short introductory call. We'll scope your inputs together and get back to you within 24 hours, with an NDA draft.
Request an Intro Call